Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Anemia, Sickle Cell D000755 34 associated lipids
Aspergillosis D001228 5 associated lipids
Blastomycosis D001759 5 associated lipids
Body Weight D001835 333 associated lipids
Burns D002056 34 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dermatomycoses D003881 17 associated lipids
Gonorrhea D006069 7 associated lipids
Hemolysis D006461 131 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hypertension D006973 115 associated lipids
Influenza, Human D007251 11 associated lipids
Leishmaniasis D007896 19 associated lipids
Mycoses D009181 18 associated lipids
Otitis Externa D010032 8 associated lipids
Peritonitis D010538 38 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Urethritis D014526 9 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Sklenár Z et al. Compounded preparations with nystatin for oral and oromucosal administration. 2013 Jul-Aug Acta Pol Pharm pmid:23923400
Giuliano S et al. Candidemia in Neurosurgical Intensive Care Unit: preliminary analysis of the effect of topical Nystatin prophylaxis and adequate source control on patients with early tracheostomy intubation. 2013 Jan-Feb Ann Ig pmid:23435780
Silva S et al. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic. 2013 Med. Mycol. pmid:22803822
Melkoumov A et al. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans. 2013 J. Antimicrob. Chemother. pmid:23620465
Kanlaya R et al. Macropinocytosis is the major mechanism for endocytosis of calcium oxalate crystals into renal tubular cells. 2013 Cell Biochem. Biophys. pmid:23695784
Chen Y et al. Antifungal mechanism of essential oil from Anethum graveolens seeds against Candida albicans. 2013 J. Med. Microbiol. pmid:23657528
Demirel G et al. Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants. 2013 Eur. J. Pediatr. pmid:23703468
Monteiro DR et al. Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. 2013 Mycoses pmid:23773119
El-Wahidi M et al. [Bio-guided isolation of an antifungal from Haliclona enamela collected from Jorf Lasfar port, Morocco]. 2013 J Mycol Med pmid:23726234
Maroszyńska M et al. Antibiotics sensitivity of Candida clinical and food-borne isolates. 2013 Acta Biochim. Pol. pmid:24432323